Lung Neoplasms: all 7,333 studies
Page 64 of 74. Open to participants first (1,554), then studies with results posted, then the rest; newest registration first within each.
- Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone or Combined Radiation Therapy and ChemotherapyCompletedNCT00738452Phase 1
- A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung CancerTerminatedNCT00738387Phase 3
- Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain MetastasesWithdrawnNCT00738335Phase 1
- Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung CancerCompletedNCT00737867Phase 3
- First-Line Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryStatus unknownNCT00736814Phase 2
- Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00734890Phase 1
- Optical Coherence Tomography of the Airway for Lung Cancer or Lung DiseaseWithdrawnNCT00733252
- Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by SurgeryCompletedNCT00732563Not applicable
- Phase I Study of Induction Therapy With VELCADE and Vorinostat in Patients With Surgically Resectable Non-Small Cell Lung CancerCompletedNCT00731952Phase 1
- Protocol for Primary Fractionated Stereotactic Body Radiation Therapy for Stage T1 - T3N0 Non Small Cell Lung Carcinoma.Status unknownNCT00727350Phase 2
- Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung CancerStatus unknownNCT00722969Phase 2
- An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing ChemotherapyTerminatedNCT00721981
- A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung CancerCompletedNCT00717938Phase 3
- A Study of Serum Protein Profiling in Patients With Non-Small Cell Lung Cancer Treated With Gefitinib or ErlotinibCompletedNCT00717847
- Physical Activity Intervention for Lung Cancer SurvivorsCompletedNCT00717795
- Genetic Polymorphisms in UGT1A6 and UGT2B7 in Asian Population: Association With Lung Cancer PhenotypeStatus unknownNCT00717353
- Detection of EGFR Mutations in the Blood of Patients With Non-small Cell Lung Cancer: a Feasibility StudyCompletedNCT00717002
- Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00716534Phase 2
- Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and RadiationCompletedNCT00716157
- Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung CancerTerminatedNCT00714246Phase 1
- Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00708812Phase 2
- Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer PatientsCompletedNCT00708448Phase 1
- Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung CancerCompletedNCT00707304Phase 3
- Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung CancerTerminatedNCT00707252Phase 1
- Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung CancerStatus unknownNCT00706862Phase 3
- Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung CancerTerminatedNCT00705549Phase 2
- Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic TherapyCompletedNCT00702975Phase 2
- Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung CancerTerminatedNCT00702572Phase 1
- Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung CancerCompletedNCT00702182Phase 1
- Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung CancerTerminatedNCT00701870Phase 2
- Study of Oral Vorinostat in Combination With Topotecan in Patients With Chemosensitive Recurrent SCLCTerminatedNCT00697476Phase 1/2
- Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLCStatus unknownNCT00697333Phase 2
- Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) RegionStatus unknownNCT00693836
- Gated Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Inoperable NSCLCTerminatedNCT00692380Phase 1
- Trial of Either Surgery or Stereotactic Radiotherapy for Early Stage (IA) Lung CancerTerminatedNCT00687986Phase 3
- Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung CancerCompletedNCT00687817Phase 2
- Docetaxel - Carboplatin As Second Line Treatment in Patients with Small Cell Lung CancerCompletedNCT00686985Phase 2
- Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)CompletedNCT00686322Phase 4
- Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their CaregiversCompletedNCT00684801
- An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and NeckApproved for marketingNCT00684385
- Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC)CompletedNCT00684099Phase 1/2
- A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC)CompletedNCT00682981Phase 1/2
- The Effect of Berries on Lung Cancer TumorsTerminatedNCT00681512Not applicable
- A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung CancerCompletedNCT00680940Phase 2
- Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT00678964Phase 2
- Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line ChemotherapyCompletedNCT00676507Phase 3
- Positron Emission Tomography (PET)/Computed Tomography (CT) and Roentgen in Lung Cancer: Evaluation of Patients in General PracticeStatus unknownNCT00675168Phase 4
- Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung CancerStatus unknownNCT00674258Phase 1/2
- An Open-label, Phase I Trial of Intravenous ASA404 Administered in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00674102Phase 1
- Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung CancerStatus unknownNCT00673777Phase 1/2
- Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous TreatmentCompletedNCT00673569Phase 2
- Early Detection of Lung Cancer Via Bi-plane Correlation Chest ImagingCompletedNCT00673283Early Phase 1
- Angiogenesis With Positron Emission Tomography (PET) Tracer UptakeCompletedNCT00671242
- Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsCompletedNCT00667641Phase 1
- NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or LymphomaCompletedNCT00667082Phase 1
- A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)CompletedNCT00666692Phase 1
- Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung CancerStatus unknownNCT00663689Phase 2
- ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung CancerTerminatedNCT00662597Phase 3
- Lobectomy and Mediastinal Radiochemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer Responding to Induction ChemotherapyTerminatedNCT00661011Phase 2
- Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or LymphomaCompletedNCT00659568Phase 1
- Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung CancerCompletedNCT00658580Phase 3
- Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC)Status unknownNCT00657423Phase 3
- Everolimus and Vatalanib in Treating Patients With Advanced Solid TumorsCompletedNCT00655655Phase 1
- A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00654758Phase 1
- Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung CancerCompletedNCT00653250Not applicable
- Phase 2 Study of S-1 as 2nd Line Therapy in Advanced Non-Small Cell Lung CancerCompletedNCT00652561Phase 2
- Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00651508Phase 2
- Phase II Trial of Consolidative Thoracic Radiotherapy for Extensive Stage Small Cell Lung CancerCompletedNCT00643396Phase 2
- Quantifying Lung Tumor Movement Under Deep Inspiration Breath HoldsCompletedNCT00643370
- CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung CancerStatus unknownNCT00643318Phase 2
- A Genetic Substudy Associated With the Avastin (Bevacizumab) Study MO19390 in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.TerminatedNCT00642824Phase 2
- Outcome of Patients With Lung Masses Who Are Treated With Radiofrequency Ablation (RFA)CompletedNCT00641238
- Breath Test for Early Detection of Lung CancerCompletedNCT00639067
- Correlation of X-ray and Pathology With Needle Biopsy of Lung TumorsWithdrawnNCT00638625
- False/Negative Rate of Lung Percutaneous Needle BiopsyCompletedNCT00638352
- Tarceva Italian Lung Optimization tRialStatus unknownNCT00637910Phase 3
- Feasibility of Exercise With Post-Op Lung Cancer PatientsCompletedNCT00636571Not applicable
- Phase I Study of Vorinostat and Sorafenib in Advanced CancerCompletedNCT00635791Phase 1
- Phase II Study of Valproate and Doxorubicin in Malignant MesotheliomaCompletedNCT00634205Phase 2
- Multiple-Vaccine Therapy in Treating Patients With Non-small Cell Lung CancerCompletedNCT00633724Phase 1
- Randomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung CancerTerminatedNCT00633568Phase 3
- Safety of Adding IMO-2055 to Erlotinib + Bevacizumab in 2nd Line Treatment for Patients With NSCLCCompletedNCT00633529Phase 1
- Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) MalignancyTerminatedNCT00629187Phase 1
- CT Scans in Screening for Lung Cancer in Current and Former SmokersCompletedNCT00625690
- Bortezomib and Cetuximab in Treating Patients With Advanced Solid TumorsCompletedNCT00622674Phase 1
- Phase I Safety and Tolerability Study of Cediranib (RECENTIN™, AZD2171) in Combination With Chemo in First Line Lung Cancer PatientsCompletedNCT00621361Phase 1
- Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLCCompletedNCT00620971Phase 2
- Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung CancerCompletedNCT00620347Phase 2
- Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid TumorsCompletedNCT00620295Phase 1
- Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC IIIStatus unknownNCT00620269Phase 2
- Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lung CancerTerminatedNCT00619021Phase 1
- Effect of Pulmonary Rehabilitation on Surgical Outcomes in the Cancer SettingActive, not recruitingNCT00618553Phase 2
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryStatus unknownNCT00616785Phase 2
- Gefitinib in Treating Patients With Stage IIIA Non-Small Cell Lung CancerStatus unknownNCT00616499Phase 2
- Paclitaxel and Carboplatin With or Without Nitroglycerin in Treating Patients With Previously Untreated Stage III or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00616031Phase 2
- Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IVCompletedNCT00615758Phase 2
- Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IVCompletedNCT00614965Phase 2
- Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung CancerStatus unknownNCT00614809Phase 2
- DNA Repair and Genetic Susceptibility to Lung CancerCompletedNCT00611598
- Prevalence+Significance of Paraneoplastic Autoantibodies in Many CancersCompletedNCT00608452